Lawrence C Van Atta, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 800-748-4868 Fax: 801-733-5872 |
Scott Miller, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 801-310-8458 |
Jay H Gassman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 800-748-4868 Fax: 801-733-5872 |
Joshua S Vincent, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 435-637-4800 |
Mr. Bryce Robert Dougal, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 N Hospital Dr, Price, UT 84501 Phone: 435-637-4800 |
News Archive
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
Chronic obstructive pulmonary disease (COPD) has a higher hospitalization rate and a higher hospital readmission rate than heart failure, angina, and other serious chronic diseases.
Patient Home Monitoring, a new company focused on in-home cardiology healthcare services, today released its post Reverse Take Over third quarter financial results, which primarily represent the period from the RTO on June 2, 2010 to June 30, 2010.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is featuring its industry-leading range of instrumentation, equipment, consumables and software used for food safety testing at the AOAC International annual meeting and exposition in Philadelphia from Sept. 11-17.
A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.
› Verified 9 days ago